iShares STOXX Europe 600 Health Care UCITS ETF (DE) (ETR:EXV4)
Germany · Delayed Price · Currency is EUR 113.38
+2.02 (1.81%)
Apr 1, 2026, 5:36 PM CET
ETR:EXV4 Holdings Information
ETR:EXV4 is an equity ETF with a total of 83 individual holdings. The top holdings are AstraZeneca stock at 15.51%, Novartis AG at 14.87%, Roche Holding AG at 14.78%, Novo Nordisk at 6.19%, and GSK plc at 6.03%.
Total Holdings
83
Top 10 Percentage
74.01%
Asset Class
Equity
ETF Category
Health Care
Assets
683.26M
PE Ratio
19.37
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LON: AZN | AstraZeneca PLC | 15.51% |
| 2 | SWX: NOVN | Novartis AG | 14.87% |
| 3 | SWX: ROP | Roche Holding AG | 14.78% |
| 4 | CPH: NOVO.B | Novo Nordisk A/S | 6.19% |
| 5 | LON: GSK | GSK plc | 6.03% |
| 6 | EPA: SAN | Sanofi | 5.74% |
| 7 | EPA: EL | EssilorLuxottica Société anonyme | 3.80% |
| 8 | SWX: LONN | Lonza Group AG | 2.37% |
| 9 | LON: HLN | Haleon plc | 2.36% |
| 10 | ETR: BAYN | Bayer Aktiengesellschaft | 2.35% |
| 11 | EBR: ARGX | argenx SE | 2.33% |
| 12 | SWX: ALC | Alcon Inc. | 2.04% |
| 13 | EBR: UCB | UCB SA | 1.95% |
| 14 | SWX: SDZ | Sandoz Group AG | 1.82% |
| 15 | SWX: GALD | Galderma Group AG | 1.61% |
| 16 | n/a | EUR - Spendable Cash | 1.16% |
| 17 | AMS: PHIA | Koninklijke Philips N.V. | 1.16% |
| 18 | ETR: FRE | Fresenius SE & Co. KGaA | 1.13% |
| 19 | CPH: NSIS.B | Novozymes A/S | 1.09% |
| 20 | CPH: GMAB | Genmab A/S | 0.91% |
| 21 | ETR: MRK | Merck KGaA | 0.86% |
| 22 | ETR: SHL | Siemens Healthineers AG | 0.84% |
| 23 | LON: SN | Smith & Nephew plc | 0.76% |
| 24 | SWX: STMN | Straumann Holding AG | 0.67% |
| 25 | SWX: SOON | Sonova Holding AG | 0.58% |
As of Mar 26, 2026